Akoya BioSciences/AKYA

$5.76

6.27%
-
1D1W1MYTD1YMAX

About Akoya BioSciences

Akoya Biosciences, Inc. is a life sciences technology company. The Company delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology imager featuring rapid whole-slide multispectral scanning of up to seven colors with an 80-slide capacity. It offers a contract research services laboratory, which is called Advanced Biopharma Solutions (ABS).

Ticker

AKYA

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Brian McKelligon

Employees

171

Headquarters

Marlborough, United States

AKYA Metrics

BasicAdvanced
$269.43M
Market cap
-
P/E ratio
-$1.76
EPS
-
Beta
-
Dividend rate

What the Analysts think about AKYA

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 8 analysts.
58.51% upside
High $12.00
Low $7.00
$5.76
Current price
$9.13
Average price target

AKYA Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-51.19% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$25.2M
7.23%
Net income
$-12.9M
-37.98%
Profit margin
-51.19%
-42.16%

AKYA Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 28.91%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.50
-$0.49
-$0.51
-$0.26
-
Expected
-$0.43
-$0.48
-$0.44
-$0.37
-$0.27
Surprise
16.28%
1.48%
15.16%
-28.91%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Akoya BioSciences stock

Buy or sell Akoya BioSciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing